1. Home
  2. NRXP vs SAIH Comparison

NRXP vs SAIH Comparison

Compare NRXP & SAIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • SAIH
  • Stock Information
  • Founded
  • NRXP 2015
  • SAIH 2019
  • Country
  • NRXP United States
  • SAIH Singapore
  • Employees
  • NRXP N/A
  • SAIH N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • SAIH
  • Sector
  • NRXP Health Care
  • SAIH
  • Exchange
  • NRXP Nasdaq
  • SAIH NYSE
  • Market Cap
  • NRXP 48.5M
  • SAIH 17.1M
  • IPO Year
  • NRXP N/A
  • SAIH N/A
  • Fundamental
  • Price
  • NRXP $4.01
  • SAIH $0.70
  • Analyst Decision
  • NRXP Strong Buy
  • SAIH
  • Analyst Count
  • NRXP 3
  • SAIH 0
  • Target Price
  • NRXP $31.67
  • SAIH N/A
  • AVG Volume (30 Days)
  • NRXP 2.8M
  • SAIH 89.5K
  • Earning Date
  • NRXP 11-14-2024
  • SAIH 11-13-2024
  • Dividend Yield
  • NRXP N/A
  • SAIH N/A
  • EPS Growth
  • NRXP N/A
  • SAIH N/A
  • EPS
  • NRXP N/A
  • SAIH N/A
  • Revenue
  • NRXP N/A
  • SAIH $6,954,000.00
  • Revenue This Year
  • NRXP N/A
  • SAIH N/A
  • Revenue Next Year
  • NRXP N/A
  • SAIH N/A
  • P/E Ratio
  • NRXP N/A
  • SAIH N/A
  • Revenue Growth
  • NRXP N/A
  • SAIH N/A
  • 52 Week Low
  • NRXP $1.10
  • SAIH $0.54
  • 52 Week High
  • NRXP $7.33
  • SAIH $1.80
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 61.48
  • SAIH N/A
  • Support Level
  • NRXP $3.20
  • SAIH N/A
  • Resistance Level
  • NRXP $6.01
  • SAIH N/A
  • Average True Range (ATR)
  • NRXP 0.95
  • SAIH 0.00
  • MACD
  • NRXP 0.11
  • SAIH 0.00
  • Stochastic Oscillator
  • NRXP 56.52
  • SAIH 0.00

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About SAIH SAIHEAT LIMITED

Saiheat Ltd develops technologies for the advanced Computing Center Ecosystem (ACCE), a next-gen computing center featuring high-performance servers, advanced liquid cooling, and systems for capturing and recycling computing heat. It aims to reduce the carbon footprint of Bitcoin mining and AI operations.

Share on Social Networks: